AVAH logo

AVEANNA HEALTHCARE HOLDINGS

AVAHNASDAQ
πŸ† #1787 by market capUS Equity
$582.71β–² $51.40 (+8.82%)
Simulated price
πŸ””
Track AVAH
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 8.8%
7dβ–² 4304.5%
14dβ–² 3966.4%
30dβ–² 4276.3%
ytdβ–² 7036.7%
1yβ–² 6473.2%
🏦Market Cap
$2.70B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+20.2%
Healthy
πŸ“ŠGross Margin
31.9%
Moderate
πŸ’΅FCF Margin
6.4%
Moderate
βš–οΈP/S Ratio
1.0x
Cheap
Otter Score
56
Weak

Trading Snapshot

Day Range
$580.58 – $589.76
52-Week Range
$5.93 – $14.71
Volume
$2.82B
Avg Volume
$3.38B
Shares Outstanding
217.8M
Next Earnings
Dec 4, 2026

Fundamentals Snapshot

Annual Revenue
$2.60B
Last Q Revenue
$629M
P/E Ratio
9.3
P/S Ratio
1.0x
EPS (TTM)
$1.26
Dividend Yield
0.00%

Why Investors Own AVAH

  • βœ“High-growth profile β€” revenue up -5.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 37% gross margin and 28% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

AVAH logo

AVEANNA HEALTHCARE HOLDINGS

AVAH
Financial Trends
Revenue (TTM)The total money the company brought in from sales, before subtracting any costs.
$2.60Bβ–Ό βˆ’1.3% YoY
Gross Margin (TTM)Of every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
37.2%β–² +2.0% YoY
Operating Income (TTM)Profit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$687Mβ–Ό βˆ’1.3% YoY
Free Cash Flow (TTM)Cash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$729Mβ–Ό βˆ’1.3% YoY
StockOtter Β· stockotter.space

About AVEANNA HEALTHCARE HOLDINGS

Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States. The company delivers a range of critical offerings, including private duty nursing (PDN), adult home health and hospice care, in-home pediatric therapy, and enteral nutrition services. Its patient-centered approach allows individuals to receive essential medical care within their own homes, effectively reducing the need for costly institutional settings such as hospitals. The company's operations are structured into three key segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment provides specialized private duty nursing, which includes skilled nursing care for medically fragile children at home, nursing support in school environments, and services at pediatric day healthcare centers. This segment also offers employer-of-record support, personal care services, and pediatric therapy (physical, occupational, and speech) provided both in clinics and patients' residences. The HHH segment focuses on home health services, encompassing in-home skilled nursing, physical, occupational, and speech therapy, as well as medical social work and aide assistance. Furthermore, it delivers hospice services, offering compassionate care to patients and their families when life-limiting illnesses no longer respond to curative treatments. The MS segment supplies enteral nutrition products and other vital medical supplies to adults and children, distributed on either a scheduled or as-needed basis. Founded in 2016, Aveanna Healthcare Holdings Inc. is headquartered in Atlanta, Georgia.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Price Target

β“˜
Average Target
$659.32
β–² +13.1% Upside
High Target$819.26
Low Target$591.90
Based on 13 analysts

Latest News & Updates